Sensei Biotherapeutics Inc is a biotechnology business based in the US. Sensei Biotherapeutics Inc shares (SNSE) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.60 – an increase of 25.03% over the previous week. Sensei Biotherapeutics Inc employs 28 staff and has a market cap (total outstanding shares value) of 0.00.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.60 |
|---|---|
| 52-week range | $0.38 - $1.94 |
| 50-day moving average | $0.52 |
| 200-day moving average | $0.78 |
| Wall St. target price | $4.13 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-1.19 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.5211 from 2024-11-22
| 1 week (2024-11-18) | 3.80% |
|---|---|
| 1 month (2024-10-25) | -6.93% |
| 3 months (2024-08-23) | -12.38% |
| 6 months (2024-05-24) | -34.04% |
| 1 year (2023-11-24) | -20.68% |
|---|---|
| 2 years (2022-11-25) | -62.78% |
| 3 years (2021-11-24) | 8.27 |
| 5 years (2019-11-22) | N/A |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -27.03% |
| Return on equity TTM | -45.17% |
| Profit margin | 0% |
| Book value | $2.59 |
| Market Capitalization | $12.2 million |
TTM: trailing 12 months
We're not expecting Sensei Biotherapeutics Inc to pay a dividend over the next 12 months.
You may also wish to consider:
Over the last 12 months, Sensei Biotherapeutics Inc's shares have ranged in value from as little as $0.384 up to $1.94. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sensei Biotherapeutics Inc's is 0.059. This would suggest that Sensei Biotherapeutics Inc's shares are less volatile than average (for this exchange).
To put Sensei Biotherapeutics Inc's beta into context you can compare it against those of similar companies.
Sensei Biotherapeutics, Inc. , an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. It also offers SNS-101, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-103 and SNS-102, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. It has a collaboration with The University of Washington to conduct preclinical studies for its SNS-101 program. The company was formerly known as Panacea Pharmaceuticals, Inc.
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
5 Betterment robo-advisor alternatives to consider when building your portfolio.
What you need to know about investing in the leading indicator for the overall US stock market.
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
Check out the best-performing ETFs so far in 2024.
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.